Abstract
We read with great interest the article by Hoff et al. on the applicability of visualization of fluorescence in situ hybridization (FISH) probes by dual-color chromogenic in situ hybridization (CISH) and totally agree about the need to perform studies on a larger number of samples to confirm their data. In our laboratory, we have been using this technique for 1 year, and to date our sample is composed of 40 cases tested for HER2/centromere 17 status by FISH and subsequent CISH conversion. In our sample, the concordance between FISH and CISH assays is 100%, in complete agreement with the results reported by Hoff et al. As a matter of fact, as we show in the figure, all pairs of ratio values were consistently above or under the cutoff in every case.
Lingua originale | English |
---|---|
pagine (da-a) | 347-348 |
Numero di pagine | 2 |
Rivista | American Journal of Clinical Pathology |
Volume | 134 |
Stato di pubblicazione | Pubblicato - 2010 |
Keywords
- breast
- cancer